Clinical Trial Update: Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

View source ↗

Summary

A clinical trial evaluating HRCT patterns in systemic sclerosis-associated interstitial lung disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis-associated Interstitial Lung Disease

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Systemic Sclerosis, Interstitial Lung Disease | Status: RECRUITING